Executive Assistant (Medical Affairs)
DBV Technologies
Summary
This role will be a trusted and key member of the Medical Affairs Team who will manage general administration tasks required to maximize team efficiency. Perform all administrative duties as needed.
Job description
Key Responsibilities
- Act as a central point of contact for the Head of Medical Affairs to schedule meetings with internal and external partners, including key opinion leaders, healthcare professionals, and advisory board members
- Coordinate domestic and international travel arrangements according to DBV travel policy, including travel to medical congresses and scientific meetings
- Be the main point of contact for the Head of Medical Affairs in the cross-functional process of executing all required documents
- Provide budget management support including initiating and tracking purchase order requests and approvals, and invoice receipts and approvals in the accounts payable system
- Prepare and coordinate Head of Medical Affairs expense reports adhering to DBV policy and ensuring timely submission
- Support the coordination of contracts and payments for external experts, consultants, and vendors (e.g., advisory boards, speaker engagements, investigator-initiated studies) in compliance with company policy and applicable transparency requirements
- Organize and periodically attend on- and off-site Medical Affairs Team meetings with external partners, including logistics and meeting materials (e.g., agenda, attendee list) preparation
- Assist with logistics for medical congresses, advisory boards, and scientific exchange events
- Create and edit PowerPoint presentations, Excel spreadsheets, and Word documents fit for purpose from time to time
Qualifications
- Experience in a similar role within the pharmaceutical industry with a global organization
- Experience working with Medical Affairs, Clinical Development, or Regulatory teams preferred
- Familiarity with pharmaceutical compliance requirements (e.g., HCP engagement, fair market value, and transparency/Sunshine Act reporting) preferred
- Advanced Word, Excel, PowerPoint, and Outlook skills
- Willingness to take on a variety of tasks and demonstrate a flexible approach in assisting others when required
- Ability to work independently
- Must be detail oriented
- Excellent interpersonal skills
- Ability to handle confidential and scientific information with discretion
- Willingness to travel occasionally if needed
Requirements
- Experience in a similar role within the pharmaceutical industry with a global organization
- Experience working with Medical Affairs, Clinical Development, or Regulatory teams preferred
- Familiarity with pharmaceutical compliance requirements (e.g., HCP engagement, fair market value, and transparency/Sunshine Act reporting) preferred
- Advanced Word, Excel, PowerPoint, and Outlook skills
- Willingness to take on a variety of tasks and demonstrate a flexible approach in assisting others when required
- Ability to work independently
- Must be detail oriented
- Excellent interpersonal skills
- Ability to handle confidential and scientific information with discretion
- Willingness to travel occasionally if needed
Company overview
DBV Technologies is a global clinical-stage biopharmaceutical company pioneering epicutaneous immunotherapy (EPIT) through its innovative Viaskin™ patch technology platform. Founded by pediatricians in 2002, the company is dedicated to developing safe and effective treatments for food allergies and immunologic diseases with significant unmet medical needs. DBV's core technology involves delivering biologically active compounds through intact skin to re-educate the immune system, offering a non-invasive alternative to traditional allergy treatments. The company's primary focus is on developing the Viaskin peanut patch for pediatric patients with peanut allergy, with ongoing Phase 3 clinical trials across different age groups. Headquartered in Châtillon, France, with operations in Warren, New Jersey, DBV maintains a global presence and is publicly traded on Euronext Paris and Nasdaq. The company's pipeline also includes programs for cow's milk allergy, eosinophilic esophagitis, autoimmune disorders, and vaccine applications, demonstrating the broad potential of its patch-based immunotherapy platform.